Search Results - "METRA, Marco"

Heart failure by Metra, Marco, MD, Teerlink, John R, MD

“…Summary Heart failure is common in adults, accounting for substantial morbidity and mortality worldwide. Its prevalence is increasing because of ageing of the…”
Get full text

Treatment of functional mitral regurgitation in chronic heart failure: can we get a ‘proof of concept’ from the MITRA‐FR and COAPT trials? by Senni, Michele, Adamo, Marianna, Metra, Marco, Alfieri, Ottavio, Vahanian, Alec

“…Functional mitral regurgitation (FMR) is associated with poor outcomes in patients with heart failure (HF). However, it is not clear whether FMR is just a…”
Get full text

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure by Bhatt, Deepak L, Szarek, Michael, Steg, P. Gabriel, Cannon, Christopher P, Leiter, Lawrence A, McGuire, Darren K, Lewis, Julia B, Riddle, Matthew C, Voors, Adriaan A, Metra, Marco, Lund, Lars H, Komajda, Michel, Testani, Jeffrey M, Wilcox, Christopher S, Ponikowski, Piotr, Lopes, Renato D, Verma, Subodh, Lapuerta, Pablo, Pitt, Bertram

“…Patients with diabetes and recent worsening heart failure that had led to hospitalization were randomly assigned to receive sotagliflozin or placebo. At a…”
Get full text

Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy by Inciardi, Riccardo M, Adamo, Marianna, Lupi, Laura, Cani, Dario S, Di Pasquale, Mattia, Tomasoni, Daniela, Italia, Leonardo, Zaccone, Gregorio, Tedino, Chiara, Fabbricatore, Davide, Curnis, Antonio, Faggiano, Pompilio, Gorga, Elio, Lombardi, Carlo M, Milesi, Giuseppe, Vizzardi, Enrico, Volpini, Marco, Nodari, Savina, Specchia, Claudia, Maroldi, Roberto, Bezzi, Michela, Metra, Marco

“…Abstract Aims To compare demographic characteristics, clinical presentation, and outcomes of patients with and without concomitant cardiac disease,…”
Get full text

COVID‐19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease by Tomasoni, Daniela, Italia, Leonardo, Adamo, Marianna, Inciardi, Riccardo M., Lombardi, Carlo M., Solomon, Scott D., Metra, Marco

“…Patients with cardiovascular disease and, namely, heart failure are more susceptible to coronavirus disease 2019 (COVID‐19) and have a more severe clinical…”
Get full text

Highlights in heart failure by Tomasoni, Daniela, Adamo, Marianna, Lombardi, Carlo Mario, Metra, Marco

“…Heart failure (HF) remains a major cause of mortality, morbidity, and poor quality of life. It is an area of active research. This article is aimed to give an…”
Get full text

The myth of ‘stable’ coronary artery disease by Fox, Keith A. A., Metra, Marco, Morais, João, Atar, Dan

“…Patients with known cardiovascular disease who have not had a recent acute event are often referred to as having stable coronary artery disease (CAD). The…”
Get full text

Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology by Mullens, Wilfried, Damman, Kevin, Testani, Jeffrey M., Martens, Pieter, Mueller, Christian, Lassus, Johan, Tang, W.H. Wilson, Skouri, Hadi, Verbrugge, Frederik H., Orso, Francesco, Hill, Loreena, Ural, Dilek, Lainscak, Mitcha, Rossignol, Patrick, Metra, Marco, Mebazaa, Alexandre, Seferovic, Petar, Ruschitzka, Frank, Coats, Andrew

“…Appropriate interpretation of changes in markers of kidney function is essential during the treatment of acute and chronic heart failure. Historically, kidney…”
Get full text

Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations by Mueller, Christian, McDonald, Kenneth, de Boer, Rudolf A., Maisel, Alan, Cleland, John G.F., Kozhuharov, Nikola, Coats, Andrew J.S., Metra, Marco, Mebazaa, Alexandre, Ruschitzka, Frank, Lainscak, Mitja, Filippatos, Gerasimos, Seferovic, Petar M., Meijers, Wouter C., Bayes‐Genis, Antoni, Mueller, Thomas, Richards, Mark, Januzzi, James L.

“…Natriuretic peptide [NP; B‐type NP (BNP), N‐terminal proBNP (NT‐proBNP), and midregional proANP (MR‐proANP)] concentrations are quantitative plasma biomarkers…”
Get full text

The role of ventricular–arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association by Ikonomidis, Ignatios, Aboyans, Victor, Blacher, Jacque, Brodmann, Marianne, Brutsaert, Dirk L., Chirinos, Julio A., De Carlo, Marco, Delgado, Victoria, Lancellotti, Patrizio, Lekakis, John, Mohty, Dania, Nihoyannopoulos, Petros, Parissis, John, Rizzoni, Damiano, Ruschitzka, Frank, Seferovic, Petar, Stabile, Eugenio, Tousoulis, Dimitrios, Vinereanu, Dragos, Vlachopoulos, Charalambos, Vlastos, Dimitrios, Xaplanteris, Panagiotis, Zimlichman, Reuven, Metra, Marco

“…Ventricular–arterial coupling (VAC) plays a major role in the physiology of cardiac and aortic mechanics, as well as in the pathophysiology of cardiac disease…”
Get full text

Adrenomedullin in heart failure: pathophysiology and therapeutic application by Voors, Adriaan A., Kremer, Daan, Geven, Christopher, ter Maaten, Jozine M., Struck, Joachim, Bergmann, Andreas, Pickkers, Peter, Metra, Marco, Mebazaa, Alexandre, Düngen, Hans‐Dirk, Butler, Javed

“…Adrenomedullin (ADM) is a peptide hormone first discovered in 1993 in pheochromocytoma. It is synthesized by endothelial and vascular smooth muscle cells and…”
Get full text

COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae by Italia, Leonardo, Tomasoni, Daniela, Bisegna, Stefano, Pancaldi, Edoardo, Stretti, Lorenzo, Adamo, Marianna, Metra, Marco

“…A close and intriguing relationship has been suggested between heart failure (HF) and coronavirus disease 2019 (COVID-19). First, COVID-19 pandemic represented…”
Get full text

Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction by Woolley, Rebecca J., Ceelen, Daan, Ouwerkerk, Wouter, Tromp, Jasper, Figarska, Sylwia M., Anker, Stefan D., Dickstein, Kenneth, Filippatos, Gerasimos, Zannad, Faiez, Marco, Metra, Ng, Leong, Samani, Nilesh, Veldhuisen, Dirk J, Lang, Chim, Lam, Carolyn S., Voors, Adriaan A.

“…Aims The lack of effective therapies for patients with heart failure with preserved ejection fraction (HFpEF) is often ascribed to the heterogeneity of…”
Get full text

The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study by Markousis‐Mavrogenis, George, Tromp, Jasper, Ouwerkerk, Wouter, Devalaraja, Matt, Anker, Stefan D., Cleland, John G., Dickstein, Kenneth, Filippatos, Gerasimos S., Harst, Pim, Lang, Chim C., Metra, Marco, Ng, Leong L., Ponikowski, Piotr, Samani, Nilesh J, Zannad, Faiez, Zwinderman, Aeilko H., Hillege, Hans L., Veldhuisen, Dirk J., Kakkar, Rahul, Voors, Adriaan A., Meer, Peter

“…Aims Inflammation is a central process in the pathophysiology of heart failure (HF), but trials targeting tumour necrosis factor (TNF)‐α were largely…”
Get full text

Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? by Cooper, Lauren B., MD, Mentz, Robert J., MD, Stevens, Susanna R., MS, Felker, G. Michael, MD, MHS, Lombardi, Carlo, MD, Metra, Marco, MD, Stevenson, Lynne W., MD, O'Connor, Christopher M., MD, Milano, Carmelo A., MD, Patel, Chetan B., MD, Rogers, Joseph G., MD

“…Highlights • We performed an analysis using ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) data of…”
Get full text

Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality by Núñez, Julio, Bayés-Genís, Antoni, Zannad, Faiez, Rossignol, Patrick, Núñez, Eduardo, Bodí, Vicent, Miñana, Gema, Santas, Enrique, Chorro, Francisco J, Mollar, Anna, Carratalá, Arturo, Navarro, Jorge, Górriz, Jose Luis, Lupón, Josep, Husser, Oliver, Metra, Marco, Sanchis, Juan

“…BACKGROUND:The prognostic value of long-term potassium monitoring and dynamics in heart failure has not been characterized completely. We sought to determine…”
Get full text

Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure Registry by Lindberg, Felix, Øigaard, Natanael, Metra, Marco, Rosano, Giuseppe M C, Dahlström, Ulf, Mol, Peter, Hage, Camilla, Lund, Lars H, Savarese, Gianluigi

“…We assessed eligibility for omecamtiv mecarbil (OM) in a real-world cohort with heart failure with reduced ejection fraction (HFrEF) according to the selection…”
Get full text

Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure by Rubio-Gracia, Jorge, Demissei, Biniyam G., ter Maaten, Jozine M., Cleland, John G., O'Connor, Christopher M., Metra, Marco, Ponikowski, Piotr, Teerlink, John R., Cotter, Gad, Davison, Beth A., Givertz, Michael M., Bloomfield, Daniel M., Dittrich, Howard, Damman, Kevin, Pérez-Calvo, Juan I., Voors, Adriaan A.

“…Congestion is the main reason for hospital admission for acute decompensated heart failure (ADHF). A better understanding of the clinical course of congestion…”
Get full text

Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine by Mebazaa, Alexandre, Yilmaz, M. Birhan, Levy, Phillip, Ponikowski, Piotr, Peacock, W. Frank, Laribi, Said, Ristic, Arsen D., Lambrinou, Ekaterini, Masip, Josep, Riley, Jillian P., McDonagh, Theresa, Mueller, Christian, deFilippi, Christopher, Harjola, Veli-Pekka, Thiele, Holger, Piepoli, Massimo F., Metra, Marco, Maggioni, Aldo, McMurray, John, Dickstein, Kenneth, Damman, Kevin, Seferovic, Petar M., Ruschitzka, Frank, Leite-Moreira, Adelino F., Bellou, Abdelouahab, Anker, Stefan D., Filippatos, Gerasimos

“…Acute heart failure is a fatal syndrome. Emergency physicians, cardiologists, intensivists, nurses and other health care providers have to cooperate to provide…”
Get full text

Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial by Teerlink, John R, Prof, Felker, G Michael, Prof, McMurray, John J V, Prof, Solomon, Scott D, Prof, Adams, Kirkwood F, MD, Cleland, John G F, Prof, Ezekowitz, Justin A, MBBCh, Goudev, Assen, Prof, Macdonald, Peter, Prof, Metra, Marco, Prof, Mitrovic, Veselin, Prof, Ponikowski, Piotr, Prof, Serpytis, Pranas, Prof, Spinar, Jindrich, Prof, Tomcsányi, János, Prof, Vandekerckhove, Hans J, MD, Voors, Adriaan A, Prof, Monsalvo, Maria Laura, MD, Johnston, James, PhD, Malik, Fady I, MD, Honarpour, Narimon, MD

“…Summary Background Impaired contractility is a feature of heart failure with reduced ejection fraction. We assessed the pharmacokinetics and effects on cardiac…”
Get full text